Archives
-
Full-Length αvβ3 Integrin Cryo-EM Structural Diversity
2026-09-17
The reference study uses high-resolution cryo-EM to resolve full-length human αvβ3 integrin across six apo conformations and five ligand-bound states, including five previously uncharacterized intermediates. Its continuum model clarifies how inhibitors engage distinct receptor conformations and provides a structural basis for more selective integrin drug design.
-
DHEA in PCOS: From Model to Assay Insight
2026-09-16
Explore how Dehydroepiandrosterone (DHEA) can be interpreted as an immune-context perturbation in PCOS research, rather than simply an ovarian stressor. This guide connects macrophage CD163 biology, granulosa-cell apoptosis, product handling, and assay design.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-09-16
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent tag for amino-group labeling of proteins, peptides, and oligonucleotides when an organic co-solvent is acceptable. It should not be selected for strictly aqueous workflows or delicate proteins that may be affected by DMSO or DMF.
-
ML385: A Practical NRF2 Inhibitor Workflow
2026-09-15
ML385 enables controlled NRF2 signaling pathway inhibition in cancer models, helping researchers separate adaptive antioxidant responses from drivers of therapeutic resistance. This workflow connects target engagement, oxidative stress modulation, ferroptosis-associated assays, and combination studies across NSCLC and emerging pancreatic cancer models.
-
Palmitic acid (N2456): Practical Protocol & QC
2026-09-15
Palmitic acid (SKU N2456) provides a characterized saturated long-chain fatty acid input for controlled lipid, metabolic, inflammatory, and signaling workflows. Because it is insoluble in water and solutions are not intended for long-term storage, use a validated ethanol or DMSO preparation with matched vehicle controls and prompt use.
-
Tofacitinib Repairs RA Macrophage Dysfunction
2026-09-14
The 2026 reference study identifies GM-CSF-reprogrammed rheumatoid arthritis macrophages as an inflammatory state coupled to oxidative stress, mitochondrial fragmentation, and metabolic imbalance. It shows that Tofacitinib reverses this linked pathology more broadly than complex I or glucose-uptake inhibition by reducing GM-CSFRα expression, suppressing STAT5 signaling, and restoring regulatory and mitochondrial features.
-
Naftifine HCl: Applied Antifungal Workflows
2026-09-14
Build more informative antifungal experiments with Naftifine HCl by pairing growth inhibition with membrane, sterol-pathway, and time-course readouts. This workflow also translates the multidimensional assay logic of muscle-cell signaling research into a practical framework for fungal mechanism studies without conflating the two biological systems.
-
Canagliflozin: Kidney–Mitochondria Framework
2026-09-13
Canagliflozin is a selective SGLT2 inhibitor whose research value extends beyond glucose lowering into proximal-tubule mitochondrial phenotyping. This evidence-led framework explains how to connect renal glucose reabsorption inhibition with bioenergetic, structural, and sex-aware assay decisions.
-
Clodronate Liposomes: In Vivo Macrophage Workflows
2026-09-12
Clodronate Liposomes provide a practical loss-of-function tool for testing whether macrophages drive tissue injury or treatment response. This guide translates hepatic ischemia-reperfusion findings into controlled depletion workflows, assay controls, and troubleshooting decisions.
-
Bufuralol hydrochloride for Organoid PK
2026-09-11
Bufuralol hydrochloride connects β-adrenergic receptor pharmacology with human pluripotent stem cell-derived intestinal organoids, enabling studies that pair receptor modulation with absorption, metabolism, and transporter readouts. This workflow offers a human-relevant complement to conventional animal and Caco-2 models while preserving practical controls for solvent effects, exposure timing, and partial agonist behavior.
-
Bradykinin (BA5201): Practical Research Workflow
2026-09-11
Bradykinin (BA5201) provides a defined research peptide input for studying endothelial vasodilation, vascular permeability modulation, smooth muscle contraction, pain mechanisms, and inflammation signaling. It is intended for freshly prepared laboratory solutions and should not be used as a diagnostic, medical, or long-term solution reagent.
-
Iron Gate Controls Mangrove Soil Carbon Preservation
2026-09-10
The reference study shows that iron redox dynamics, rather than suppression of phenol oxidase alone, primarily regulate soil organic carbon preservation across contrasting water regimes in mangrove wetlands. Its incubation design clarifies how flooding changes Fe-bound carbon availability, anaerobic mineralization, and methane constraints, providing a useful framework for interpreting redox-sensitive carbon cycling.
-
Ziprasidone Augmentation in Anxious Depression
2026-09-10
This post-hoc analysis tested whether baseline anxious depression modified the antidepressant and anxiolytic effects of ziprasidone added to escitalopram. Depression outcomes were comparable across anxiety subgroups, while the apparent anxiety benefit was not clinically significant in patients with anxious depression, highlighting the importance of moderator analysis in antidepressant research.
-
Triamcinolone: Practical Research Workflow Guide
2026-09-09
Triamcinolone provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, storage, controls, and assay qualification; the compound is for scientific research only and should not be used for diagnostic, clinical, or therapeutic purposes.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-09
Separate mRNA uptake from protein expression with one dual-fluorescence reporter. This practical workflow shows how to use Cy5 tracking and EGFP translation to validate nanoparticles, optimize transfection, and troubleshoot delivery bottlenecks.